IgM myeloma: Case report with immunophenotypic profile

American Journal of Hematology

Volumn 59, Issue 4, 1998, Pages 302-308

  Haghighi, Bijan ^a,c   Yanagihara, Ronald ^b   Cornbleet, P Joanne ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b Hazel Hawkins Hospital   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Flow cytometry; IgM; Lymphoproliferative disorders; Multiple myeloma; Waldenstrom's macroglobulinemia

Indexed keywords

DEXAMETHASONE; DOXORUBICIN; IMMUNOGLOBULIN M; MELPHALAN; PAMIDRONIC ACID; PREDNISONE; VINCRISTINE;

AGED; ANTIGEN EXPRESSION; ARTICLE; CASE REPORT; DIFFERENTIAL DIAGNOSIS; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOPHENOTYPING; LYMPHOPROLIFERATIVE DISEASE; MULTIPLE MYELOMA; MYELOMA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; WALDENSTROEM MACROGLOBULINEMIA;

AGED; AGED, 80 AND OVER; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; ANTIGENS, NEOPLASM; BONE MARROW; FEMALE; FLOW CYTOMETRY; FRACTURES, SPONTANEOUS; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN M; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; MULTIPLE MYELOMA; MYELOMA PROTEINS; TUMOR STEM CELLS; WALDENSTROM MACROGLOBULINEMIA;

EID: 0031755106     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199812)59:4<302::AID-AJH6>3.0.CO;2-Z     Document Type: Article

References (23)

1. Grogan TM, Spier CM: The B-cell immunoproliferative disorders, including multiple myeloma and amyloidosis. In Knowels DM, ed. Neoplastic Hematopathology. Baltimore: Williams and Wilkins, 1992, pp 1235-1265.
2. Callihan TR, Holbert JM, Berard CW: Neoplasms of terminal B-cell differentiation: the morphologic basis of functional diversity. In Sommers S, Rosen PP, eds. Malignant Lymphomas; A Pathology Annual Monograph. Norwalk, CT: Appleton-Century-Crofts, 1983, pp 169-268.
3. Zarrabi MH, Stark RS, Kane P, Chandors S: IgM myeloma, a distinct entity in the spectrum of B-cell neoplasia. Am J Clin Pathol 75:1-10, 1981.
4. Takahashi K, Yamamura F, and Motoyama H: IgM myeloma: Its distinction from Waldenström's macroglobulinemia. Acta Pathol Jpn 36:1553-1563, 1986.
5. Kyle RA: The spectrum of IgM monoclonal gammopathy in 430 cases. Mayo Clin Proc 62:719-731, 1987.
6. Berman HH: Waldenström's macroglobulinemia with lytic osseous lesions and plasma-cell morphology: Report of a case, Am J Clin Pathol 63:397-402, 1974.
7. Fudenberg HH, Virella G: Multiple myeloma and Waldenström macroglobulinemia: Unusual presentations. Semin Hematol 17:63-79, 1980.
8. Dimopoulos AD, Alexanian R: Waldenström's macroglobulinemia. Blood 83:1452-1459, 1994.
9. Bergsagel DE: Macroglobulinemia. In Williams WJ, Beutler E, Erslev AJ, Lichtman, eds. Hematology, Ed 4. New York: McGraw-Hill, 1990, pp 1141-1145.
10. Adner PL, Wallenius G, Werner I: Macroglobulinemia and myelomatosis. Acta Med Scand 168:431-437, 1960.
11. MacKenzie MR, Fundenberg HH: Macroglobulinemia: An analysis for forty patients. Blood 39:874-889, 1972.
12. Vermess M, Pearson KD, Einstein AB, Fahey JL: Osseous manifestations of Waldenström's macroglobulinemia. Radiology 102:497-504, 1972.
13. Welton J, Walker S, Sharp J, Herzenberg LA, Wistar R Jr, Creger WP: Macroglobulinemia with bone destruction. Am J Med 44:280-288, 1968.
14. Moulopoulos LA, Dimopoulos MA, Varma DGK, Manning JT, Johnston DA, Leeds NE, Libshitz HI: Waldenström macroglobulinemia: MR imaging of the spine and CT of the abdomen and pelvis. Radiology 188:669-673, 1993.
15. San Miguel JF, Caballaro MD, Gonzalez M, Moro MJ, Hernandez JM, Ortega F, Jiminez R, Guerras L, Romero M, Casanova F: Immunological phenotype of neoplasms involving the B cell in the last step of differentiation. Br J Haematol 62:75-83, 1986.
16. Feiner HD, Rizk CC, Finfer MD, et al.: IgM monoclonal gammopathy/Waldenström's macroglobulinemia: A morphological and immunophenotypic study of the bone marrow. Mod Pathol 3:347-356, 1990.
17. Kucharska-Pulczynska M, Ellegaard J, Hokland P: Analysis of leucocyte differentiation antigens in blood and bone marrow from patients with Waldenström's macroglobulinemia. Br J Haematol 65:395-402, 1987.
18. Tominaga N, Katagiri S, Ohnishi MN, Nakao H, Oritani K, Yagura H, Tamaki T, Kanamaya Y, Yonezawa T, Tarvi S: Analysis of surface antigen expression of human immunoglobulin-secreting cells: Phenotypic heterogeneity in normal counterparts of myeloma cells. Br J Haematol 73:302-308, 1989.
19. Ruiz-Arguelles GJ, San Miguel JF: Cell surface markers in multiple myeloma. Mayo Clin Proc 69:684-690, 1994.
20. Epstein J, Xiao H, He XY: Markers of multiple hematopoietic-cell lineages in multiple myeloma. N Engl J Med 322:664-690, 1990.
21. Durie BG, Grogan TM: CALLA-positive myeloma: An aggressive subtype with poor survival. Blood 66:229-232, 1985.
22. Anderson KC, Park EK, Bates MP, Leonard RC, Hardy R, Schlossman SF, Nadler LM: Antigens on human plasma cells identified by monoclonal antibodies. J Immunol 130:1132-1138, 1983.
23. Anderson KC, Bates MP, Slaughenhoupt B, et al.: A monoclonal antibody with reactivity restricted to normal and neoplastic plasma cells. J Immunol 132:3172-3179, 1984.